Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients

被引：20

作者：

Vitiello, Magalys ^{[1
]}

Tosti, Antonella ^{[2
]}

Abuchar, Adriana ^{[1
]}

Zaiac, Martin ^{[2
]}

Kerdel, Francisco A. ^{[1
,2
]}

机构：

[1] Univ Miami Hosp, Florida Acad Dermatol Ctr, Miami, FL 33136 USA

[2] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2013年 / 52卷 / 03期

关键词：

DOUBLE-BLIND; MODERATE; THERAPY; ADALIMUMAB; INFLIXIMAB; ARTHRITIS;

D O I：

10.1111/j.1365-4632.2011.05320.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：358 / 362

页数：5

共 11 条

[1]

Cassell SE, 2007, J RHEUMATOL, V34, P123

[2] Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial [J].

Gottlieb, Alice ;

Menter, Alan ;

Mendelsohn, Alan ;

Shen, Yaung-Kaung ;

Li, Shu ;

Guzzo, Cynthia ;

Fretzin, Scott ;

Kunynetz, Rod ;

Kavanaugh, Arthur .

LANCET, 2009, 373 (9664) :633-640

[3] Psoriatic Nail Disease: Quality of Life and Treatment [J].

Gupta, Aditya K. ;

Cooper, Elizabeth A. .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 :S102-S106

[4] Therapeutic effects of a 12-week course of alefacept on nail psoriasis [J].

Korver, J. E. M. ;

Langewouters, A. M. G. ;

De Kerkhof, P. C. M. Van ;

Pasch, M. C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (10) :1252-1255

[5] Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis [J].

Luger, T. A. ;

Barker, J. ;

Lambert, J. ;

Yang, S. ;

Robertson, D. ;

Foehl, J. ;

Molta, C. T. ;

Boggs, R. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (08) :896-904

[6] Nail Psoriasis and Biologics [J].

Noiles, Kristin ;

Vender, Ronald .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (01) :1-5

[7] Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial [J].

Reich, K ;

Nestle, FO ;

Papp, K ;

Ortonne, JP ;

Evans, R ;

Guzzo, C ;

Li, S ;

Dooley, LT ;

Griffiths, CEM .

LANCET, 2005, 366 (9494) :1367-1374

[8] Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year [J].

Rich, Phoebe ;

Griffiths, Christopher E. M. ;

Reich, Kristian ;

Nestle, Frank O. ;

Scher, Richard K. ;

Li, Shu ;

Xu, Stephen ;

Hsu, Ming-Chun ;

Guzzo, Cynthia .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) :224-231

[9] Treatment of nail psoriasis with adalimumab: an open label unblinded study [J].

Rigopoulos, D. ;

Gregoriou, S. ;

Lazaridou, E. ;

Belyayeva, E. ;

Apalla, Z. ;

Makris, M. ;

Katsambas, A. ;

Ioannides, D. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (05) :530-534

[10]

Tosti A, 2009, ARCH DERMATOL, V145, P269, DOI 10.1001/archdermatol.2008.600

← 1 2 →